HUP9902068A3 - Methods and compositions for the diagnosis and treatment of cancer - Google Patents
Methods and compositions for the diagnosis and treatment of cancerInfo
- Publication number
- HUP9902068A3 HUP9902068A3 HU9902068A HUP9902068A HUP9902068A3 HU P9902068 A3 HUP9902068 A3 HU P9902068A3 HU 9902068 A HU9902068 A HU 9902068A HU P9902068 A HUP9902068 A HU P9902068A HU P9902068 A3 HUP9902068 A3 HU P9902068A3
- Authority
- HU
- Hungary
- Prior art keywords
- diagnosis
- cancer
- compositions
- treatment
- methods
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4746—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used p53
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Physics & Mathematics (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US781095P | 1995-11-30 | 1995-11-30 |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP9902068A2 HUP9902068A2 (hu) | 1999-10-28 |
HUP9902068A3 true HUP9902068A3 (en) | 2001-02-28 |
Family
ID=21728237
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9902068A HUP9902068A3 (en) | 1995-11-30 | 1996-11-27 | Methods and compositions for the diagnosis and treatment of cancer |
Country Status (19)
Country | Link |
---|---|
US (3) | US20020077313A1 (hu) |
EP (1) | EP0863984B1 (hu) |
JP (1) | JP2000501394A (hu) |
KR (1) | KR19990071795A (hu) |
CN (2) | CN1308450C (hu) |
AT (1) | ATE325872T1 (hu) |
AU (1) | AU722042B2 (hu) |
CA (1) | CA2238829A1 (hu) |
CZ (1) | CZ296810B6 (hu) |
DE (1) | DE69636120T2 (hu) |
DK (1) | DK0863984T3 (hu) |
ES (1) | ES2264145T3 (hu) |
HU (1) | HUP9902068A3 (hu) |
NO (1) | NO982481L (hu) |
NZ (1) | NZ324168A (hu) |
PL (1) | PL186018B1 (hu) |
RU (1) | RU2174409C2 (hu) |
SK (1) | SK70598A3 (hu) |
WO (1) | WO1997020047A1 (hu) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9713368A (pt) * | 1996-11-20 | 2001-09-18 | Introgen Therapeutics Inc | Processo melhorado para a produção e a purificação de vetores adenovirais |
US6689600B1 (en) * | 1998-11-16 | 2004-02-10 | Introgen Therapeutics, Inc. | Formulation of adenovirus for gene therapy |
AU2003268210A1 (en) * | 2002-08-28 | 2004-03-19 | Introgen Therapeutics Inc. | Chromatographic methods for adenovirus purification |
US20050032728A1 (en) * | 2002-12-17 | 2005-02-10 | Sidney Kimmel Cancer Center | Tumor suppression through bicistronic co-expression of p53 and p14ARF |
WO2004060408A1 (en) * | 2002-12-27 | 2004-07-22 | Introgen Therapeutics, Inc. | p53 TREATMENT OF PAPILLOMAVIRUS AND CARCINOGEN-TRANSFORMED CELLS IN HYPERPLASTIC LESIONS |
CA2518169C (en) * | 2003-03-06 | 2012-01-24 | Zhaohui Peng | A recombinant constructed by a virus vector and a human tumor suppressor gene and its use |
WO2005082422A1 (en) * | 2004-02-24 | 2005-09-09 | Introgen Therapeutics, Inc. | Combination of ad-p53 and chemotherapy for the treatment of tumours |
CN100333797C (zh) * | 2005-01-26 | 2007-08-29 | 彭朝晖 | 重组腺病毒p53制品在肿瘤治疗中的新用途 |
EP1679065A1 (en) | 2005-01-07 | 2006-07-12 | OctoPlus Sciences B.V. | Controlled release compositions for interferon based on PEGT/PBT block copolymers |
WO2006119618A1 (en) * | 2005-05-06 | 2006-11-16 | Orthosoft Inc. | Rf system for tracking objects |
WO2007090125A2 (en) * | 2006-01-30 | 2007-08-09 | Introgen Therapeutics, Inc. | Prognostic factors for anti-hyperproliferative disease gene therapy |
EP2415783B1 (en) | 2006-10-16 | 2016-12-14 | Genelux Corporation | Modified vaccinia virus strains for use in a diagnostic and therapeutic method |
US20080299182A1 (en) * | 2007-03-01 | 2008-12-04 | Shuyuan Zhang | Methods and formulations for topical gene therapy |
WO2008150496A2 (en) * | 2007-05-31 | 2008-12-11 | Genelux Corporation | Assay for sensitivity to chemotherapeutic agents |
DK2245464T3 (en) | 2008-01-25 | 2017-02-20 | Multivir Inc | P53 BIOMARKETS |
US8314068B2 (en) * | 2008-04-14 | 2012-11-20 | University Hospitals Of Cleveland | P2X7 inhibition of epithelial cancers and papillomas |
WO2009139921A2 (en) * | 2008-05-16 | 2009-11-19 | Genelux Corporation | Microorganisms for preventing and treating neoplasms accompanying cellular therapy |
RU2618688C2 (ru) | 2008-12-04 | 2017-05-10 | КьюРНА,Инк.,US | Лечение связанных с геном-супрессором опухолей заболеваний посредством ингибирования природного транскрипта в антисмысловой ориентации относительно этого гена |
ES2898235T3 (es) * | 2009-02-02 | 2022-03-04 | Glaxosmithkline Biologicals Sa | Secuencias de aminoácidos y de ácidos nucleicos de adenovirus de simio, vectores que las contienen, y sus usos |
US9050276B2 (en) | 2009-06-16 | 2015-06-09 | The Trustees Of Columbia University In The City Of New York | Autism-associated biomarkers and uses thereof |
CN108404115A (zh) | 2010-10-15 | 2018-08-17 | 纽约市哥伦比亚大学理事会 | 肥胖症-相关的基因和它们的蛋白和其用途 |
WO2013149194A1 (en) | 2012-03-29 | 2013-10-03 | The Trustees Of Columbia University In The City Of New York | Methods for treating hair loss disorders |
EP2635299B1 (en) | 2010-11-02 | 2019-07-31 | The Trustees of Columbia University in the City of New York | Methods for treating hair loss disorders |
CN104093830A (zh) | 2011-04-15 | 2014-10-08 | 吉恩勒克斯公司 | 减毒的痘苗病毒的克隆毒株及其使用方法 |
CN102352368B (zh) * | 2011-09-29 | 2013-12-04 | 苏州大学 | Ing4与osm双基因共表达载体及其应用 |
AU2012348332B2 (en) * | 2011-12-08 | 2017-06-29 | Haifeng Chen | Vectors harboring toxic genes, methods and uses therefor |
JP6052914B2 (ja) | 2012-01-12 | 2016-12-27 | シナプティクス インコーポレイテッド | 単層容量型イメージングセンサ |
EP2822572B1 (en) * | 2012-02-15 | 2020-06-10 | Aileron Therapeutics, Inc. | Peptidomimetic macrocycles |
US10039777B2 (en) | 2012-03-20 | 2018-08-07 | Neuro-Lm Sas | Methods and pharmaceutical compositions of the treatment of autistic syndrome disorders |
KR20150129847A (ko) | 2013-03-15 | 2015-11-20 | 더 트러스티스 오브 컬럼비아 유니버시티 인 더 시티 오브 뉴욕 | 융합 단백질 및 이들의 방법 |
MX2015013658A (es) * | 2013-03-27 | 2016-02-18 | Ge Healthcare As | Metodo y reactivo para preparar una composicion diagnostica. |
WO2014204814A1 (en) * | 2013-06-18 | 2014-12-24 | Dnatrix, Inc. | Treatment of brain cancer with oncolytic adenovirus |
US9552089B2 (en) | 2013-08-07 | 2017-01-24 | Synaptics Incorporated | Capacitive sensing using a matrix electrode pattern |
US10042489B2 (en) | 2013-09-30 | 2018-08-07 | Synaptics Incorporated | Matrix sensor for image touch sensing |
US20150091842A1 (en) | 2013-09-30 | 2015-04-02 | Synaptics Incorporated | Matrix sensor for image touch sensing |
US9298325B2 (en) | 2013-09-30 | 2016-03-29 | Synaptics Incorporated | Processing system for a capacitive sensing device |
US9459367B2 (en) | 2013-10-02 | 2016-10-04 | Synaptics Incorporated | Capacitive sensor driving technique that enables hybrid sensing or equalization |
US9274662B2 (en) | 2013-10-18 | 2016-03-01 | Synaptics Incorporated | Sensor matrix pad for performing multiple capacitive sensing techniques |
US9081457B2 (en) | 2013-10-30 | 2015-07-14 | Synaptics Incorporated | Single-layer muti-touch capacitive imaging sensor |
US9682123B2 (en) | 2013-12-20 | 2017-06-20 | The Trustees Of Columbia University In The City Of New York | Methods of treating metabolic disease |
US9798429B2 (en) | 2014-02-28 | 2017-10-24 | Synaptics Incorporated | Guard electrodes in a sensing stack |
CN104357408A (zh) * | 2014-03-13 | 2015-02-18 | 哈尔滨博翱生物医药技术开发有限公司 | 一种重组新城疫病毒及其应用 |
US10133421B2 (en) | 2014-04-02 | 2018-11-20 | Synaptics Incorporated | Display stackups for matrix sensor |
US9927832B2 (en) | 2014-04-25 | 2018-03-27 | Synaptics Incorporated | Input device having a reduced border region |
US9690397B2 (en) | 2014-05-20 | 2017-06-27 | Synaptics Incorporated | System and method for detecting an active pen with a matrix sensor |
JP6938372B2 (ja) * | 2014-09-30 | 2021-09-22 | ディアデム エス.アール.エル. | ヒトp53の直線状エピトープに結合する抗体及びその診断的応用 |
EP3237452A4 (en) | 2014-12-23 | 2018-12-05 | The Trustees of Columbia University in the City of New York | Fusion proteins and methods thereof |
US10175827B2 (en) | 2014-12-23 | 2019-01-08 | Synaptics Incorporated | Detecting an active pen using a capacitive sensing device |
US10990148B2 (en) | 2015-01-05 | 2021-04-27 | Synaptics Incorporated | Central receiver for performing capacitive sensing |
US9939972B2 (en) | 2015-04-06 | 2018-04-10 | Synaptics Incorporated | Matrix sensor with via routing |
US9720541B2 (en) | 2015-06-30 | 2017-08-01 | Synaptics Incorporated | Arrangement of sensor pads and display driver pads for input device |
US10095948B2 (en) | 2015-06-30 | 2018-10-09 | Synaptics Incorporated | Modulation scheme for fingerprint sensing |
US9715304B2 (en) | 2015-06-30 | 2017-07-25 | Synaptics Incorporated | Regular via pattern for sensor-based input device |
CN205028263U (zh) | 2015-09-07 | 2016-02-10 | 辛纳普蒂克斯公司 | 一种电容传感器 |
US10037112B2 (en) | 2015-09-30 | 2018-07-31 | Synaptics Incorporated | Sensing an active device'S transmission using timing interleaved with display updates |
US10067587B2 (en) | 2015-12-29 | 2018-09-04 | Synaptics Incorporated | Routing conductors in an integrated display device and sensing device |
CN106933400B (zh) | 2015-12-31 | 2021-10-29 | 辛纳普蒂克斯公司 | 单层传感器图案和感测方法 |
US11154591B2 (en) | 2016-10-14 | 2021-10-26 | The Trustees Of Columbia University In The City Of New York | Methods of treating alcohol abuse disorder |
RU2760993C1 (ru) * | 2021-02-15 | 2021-12-02 | Сергей Александрович Никитин | Способ рентгеновской терапии рака легких |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4740463A (en) * | 1984-04-13 | 1988-04-26 | Massachusetts Institute Of Technology | Methods and artificial genes for antagonizing the function of an oncogene |
ZA858044B (en) * | 1984-11-01 | 1987-05-27 | American Home Prod | Oral vaccines |
US4748022A (en) * | 1985-03-25 | 1988-05-31 | Busciglio John A | Topical composition |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
US5055400A (en) * | 1986-11-26 | 1991-10-08 | University Of Guelph | Leukotoxin gene of pasteurella haemolytica |
US5166320A (en) * | 1987-04-22 | 1992-11-24 | University Of Connecticut | Carrier system and method for the introduction of genes into mammalian cells |
US4980289A (en) * | 1987-04-27 | 1990-12-25 | Wisconsin Alumni Research Foundation | Promoter deficient retroviral vector |
US5532220A (en) * | 1987-08-31 | 1996-07-02 | The Regents Of The University Of California | Genetic mechanisms of tumor suppression |
US5017524A (en) * | 1989-02-13 | 1991-05-21 | Iscar Ltd. | Ceramic cutting tool |
US6800617B1 (en) * | 1989-03-29 | 2004-10-05 | The Johns Hopkins University | Methods for restoring wild-type p53 gene function |
US6677312B1 (en) * | 1989-03-29 | 2004-01-13 | The Johns Hopkins University | Methods for restoring wild-type p53 gene function |
US5527676A (en) * | 1989-03-29 | 1996-06-18 | The Johns Hopkins University | Detection of loss of the wild-type P53 gene and kits therefor |
US5362623A (en) * | 1991-06-14 | 1994-11-08 | The John Hopkins University | Sequence specific DNA binding by p53 |
US5328470A (en) * | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
US5585362A (en) * | 1989-08-22 | 1996-12-17 | The Regents Of The University Of Michigan | Adenovirus vectors for gene therapy |
AU663702B2 (en) * | 1991-03-06 | 1995-10-19 | Board Of Regents, The University Of Texas System | Methods and compositions for the selective inhibition of gene expression |
US5747469A (en) * | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
US6410010B1 (en) * | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
US5252479A (en) * | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
FR2688514A1 (fr) * | 1992-03-16 | 1993-09-17 | Centre Nat Rech Scient | Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant. |
US5496731A (en) * | 1993-03-25 | 1996-03-05 | Xu; Hong-Ji | Broad-spectrum tumor suppressor genes, gene products and methods for tumor suppressor gene therapy |
TW442569B (en) * | 1993-10-25 | 2001-06-23 | Canji Inc | Recombinant adenoviral vector |
CA2192442C (en) * | 1994-06-10 | 2007-09-25 | Imre Kovesdi | Complementary adenoviral vector systems and cell lines |
-
1996
- 1996-11-27 CA CA002238829A patent/CA2238829A1/en not_active Abandoned
- 1996-11-27 AT AT96942100T patent/ATE325872T1/de active
- 1996-11-27 JP JP9520700A patent/JP2000501394A/ja not_active Ceased
- 1996-11-27 RU RU98111928/14A patent/RU2174409C2/ru active
- 1996-11-27 PL PL96327009A patent/PL186018B1/pl unknown
- 1996-11-27 ES ES96942100T patent/ES2264145T3/es not_active Expired - Lifetime
- 1996-11-27 CN CNB961995858A patent/CN1308450C/zh not_active Expired - Lifetime
- 1996-11-27 HU HU9902068A patent/HUP9902068A3/hu unknown
- 1996-11-27 SK SK705-98A patent/SK70598A3/sk unknown
- 1996-11-27 NZ NZ324168A patent/NZ324168A/en not_active IP Right Cessation
- 1996-11-27 EP EP96942100A patent/EP0863984B1/en not_active Expired - Lifetime
- 1996-11-27 CN CNA2007100051249A patent/CN101028523A/zh active Pending
- 1996-11-27 DE DE69636120T patent/DE69636120T2/de not_active Expired - Lifetime
- 1996-11-27 CZ CZ0165798A patent/CZ296810B6/cs not_active IP Right Cessation
- 1996-11-27 DK DK96942100T patent/DK0863984T3/da active
- 1996-11-27 WO PCT/US1996/019083 patent/WO1997020047A1/en active IP Right Grant
- 1996-11-27 AU AU11263/97A patent/AU722042B2/en not_active Expired
- 1996-11-27 KR KR1019980704074A patent/KR19990071795A/ko active Search and Examination
-
1998
- 1998-05-29 NO NO19982481A patent/NO982481L/no not_active Application Discontinuation
-
2001
- 2001-10-01 US US09/968,958 patent/US20020077313A1/en not_active Abandoned
-
2003
- 2003-03-24 US US10/395,864 patent/US20030166603A1/en not_active Abandoned
-
2005
- 2005-08-09 US US11/200,527 patent/US20060035857A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PL186018B1 (pl) | 2003-09-30 |
NZ324168A (en) | 2004-11-26 |
RU2174409C2 (ru) | 2001-10-10 |
ES2264145T3 (es) | 2006-12-16 |
CN1308450C (zh) | 2007-04-04 |
KR19990071795A (ko) | 1999-09-27 |
DE69636120T2 (de) | 2006-11-30 |
AU722042B2 (en) | 2000-07-20 |
CN101028523A (zh) | 2007-09-05 |
EP0863984A1 (en) | 1998-09-16 |
DE69636120D1 (de) | 2006-06-14 |
CA2238829A1 (en) | 1997-06-05 |
CN1207771A (zh) | 1999-02-10 |
PL327009A1 (en) | 1998-11-09 |
CZ165798A3 (cs) | 1998-12-16 |
DK0863984T3 (da) | 2006-08-28 |
US20020077313A1 (en) | 2002-06-20 |
ATE325872T1 (de) | 2006-06-15 |
EP0863984B1 (en) | 2006-05-10 |
JP2000501394A (ja) | 2000-02-08 |
AU1126397A (en) | 1997-06-19 |
WO1997020047A1 (en) | 1997-06-05 |
HUP9902068A2 (hu) | 1999-10-28 |
US20030166603A1 (en) | 2003-09-04 |
CZ296810B6 (cs) | 2006-06-14 |
US20060035857A1 (en) | 2006-02-16 |
NO982481D0 (no) | 1998-05-29 |
NO982481L (no) | 1998-07-29 |
SK70598A3 (en) | 1999-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP9902068A3 (en) | Methods and compositions for the diagnosis and treatment of cancer | |
EP0808324A4 (en) | COMPOSITIONS AND METHODS FOR TREATING AND DIAGNOSING CARDIOVASCULAR DISEASES | |
ZA957483B (en) | Compounds and methods for the treatment of cancer | |
AU2124397A (en) | Compositions and methods for the treatment and diagnosis of cardiovascular disease | |
EP0831904A4 (en) | TREATMENT AND DIAGNOSIS OF PROSTATE CANCER | |
HUP9800033A3 (en) | Compositions for the treatment of dermatological disorders and methods for their use | |
ZA96740B (en) | Skin treatment composition | |
AU1980995A (en) | Methods and compositions for treatment of breast cancer | |
EP1007535A4 (en) | METHOD AND PREPARATIONS FOR DIAGNOSTIC AND TREATMENT OF BREAST CANCER | |
IL132287A0 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
AU7012496A (en) | Compounds and methods for treatment and diagnosis of prostate cancer | |
AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
IL114119A0 (en) | Compositions and methods for the treatment of tumors | |
AU9395998A (en) | Compositions and methods for the treatment of immune related diseases | |
GB9811598D0 (en) | Diagnosis and treatment of cancer | |
IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
AU6786898A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
AU6786598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders | |
GB9510162D0 (en) | Compositions for the treatment of skin conditions | |
IL141551A0 (en) | Compositions and methods for the treatment of immune related diseases | |
AU3655097A (en) | Brca1 compositions and methods for the diagnosis and treatment of breast cancer | |
EP0733365A3 (en) | Use of benzoquinolin-3-one for the treatment and prevention of prostate cancer | |
AU4841296A (en) | Diagnosis of and compositions and methods for the treatment of disease | |
AU8580598A (en) | Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders |